IFN‑γ and IL‑18 in conditioned media of parasite‑infected host and IL‑21‑silenced colorectal cancer cells

Ge,Peng; Ong,Ching Yi; Abdalkareem,Abdalla Eshtiyag; Khoo,Boon Yin; Yuan,Bo

doi:10.3892/etm.2020.9535

IFN‑γ and IL‑18 in conditioned media of parasite‑infected host and IL‑21‑silenced colorectal cancer cells

Authors:
- Peng Ge
- Ching Yi Ong
- Abdalla Eshtiyag Abdalkareem
- Boon Yin Khoo
- Bo Yuan
View Affiliations

Affiliations: Department of General Surgery, Xi'an Central Hospital, Xi'an, Shaanxi 710003, P.R. China, Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia
Published online on: November 27, 2020 https://doi.org/10.3892/etm.2020.9535
Article Number: 103
Copyright: © Ge et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The presence of certain soluble factors may provide a possible selective advantage for a parasite to gradually modify cell proliferation in neighbouring cells, which may result in chronic diseases. These soluble factors present in the conditioned medium also allow the parasite to invade rapidly into more host cells. The present study aimed to determine the levels of a group of type 1 T helper (Th1) cytokines in the conditioned media of host cells infected with parasites and in IL‑21‑silenced colorectal cancer cells. The conditioned media of human foreskin fibroblasts (HFFs) parasitized with the RH and ME49 strains of Toxoplasma gondii for 10 days were prepared, and subsequently the levels of the Th1 cytokines in the conditioned media were determined by ELISA. HFFs were incubated with the growth media containing selected soluble factors, and cell proliferation markers were subsequently analysed by reverse transcription‑quantitative PCR. The mRNA expression level of cell proliferation markers was also examined in IL‑21‑silenced HCT116 cells, where the levels of soluble factors in the conditioned media were also determined as aforementioned. The results of the present study demonstrated that HFFs parasitized with ME49 released elevated levels of IFN‑γ and lower levels of IL‑18 into the conditioned medium compared with the controls. These phenomena were not observed in the conditioned medium of HFFs parasitized with RH. Similar levels of these soluble factors were also detected in the conditioned medium of IL‑21‑silenced HCT116 cells. The results of the present study also revealed that Ki67 and proliferating cell nuclear antigen mRNA expression was altered in host cells incubated with various levels of IFN‑γ and IL‑18, as well as in IL‑21‑silenced HCT116 cells compared with the respective controls. In conclusion, the current study provided preliminary evidence on the fundamental molecular mechanisms of host‑parasite interactions that result in chronic diseases, which may aid in the treatment of these diseases in the relevant endemic regions.

View Figures

View References

1	Ferra B, Holec-Gąsior L and Grąźlewska W: Toxoplasma gondii recombinant antigens in the serodiagnosis of toxoplasmosis in domestic and farm animals. Animals (Basel). 10(1245)2020.PubMed/NCBI View Article : Google Scholar
2	Galeh TM, Sarvi S, Montazeri M, Moosazadeh M, Nakhaei M, Shariatzadeh SA and Daryani A: Global status of Toxoplasma gondii seroprevalence in rodents: A systematic review and meta-analysis. Front Vet Sci. 7(461)2020.PubMed/NCBI View Article : Google Scholar
3	Mordue DG, Monroy F, La-Regina M, Dinarello CA and Sibley LD: Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 167:4574–4584. 2001.PubMed/NCBI View Article : Google Scholar
4	Gavrilescu LC and Denkers EY: IFN-gamma overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J Immunol. 167:902–909. 2001.PubMed/NCBI View Article : Google Scholar
5	Hakimi MA, Olias P and Sibley LD: Toxoplasma effectors targeting host signaling and transcription. Clin Microbiol Rev. 30:615–645. 2017.PubMed/NCBI View Article : Google Scholar
6	Helmby H, Takeda K, Akira S and Grencisa RK: Interleukin (Il)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J Exp Med. 194:355–364. 2001.PubMed/NCBI View Article : Google Scholar
7	Abdalkareem EA, Ong CY, Lim BH and Khoo BY: Neutralising FGF4 protein in conditioned medium of IL-21-silenced HCT116 cells restores the invasiveness of the colorectal cancer cells. Cytotechnology. 70:1363–1374. 2018.PubMed/NCBI View Article : Google Scholar
8	Khan A and Grigg ME: Toxoplasma gondii: Laboratory maintenance and growth. Curr Protoc Microbiol. 44:20C.1.1–20C.1.17. 2017.PubMed/NCBI View Article : Google Scholar
9	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
10	Eshtiyag A, Lim BH and Khoo BY: Silencing of IL21 in HT29 and HCT116 cells to determine its role in the proliferation of colorectal cancer associated with Schistosoma mansoni infection. Australian J Basic Applied Sci. 9:39–44. 2015.
11	Eberl M, Beck E, Coulson PS, Okamura H, Wilson RA and Mountford AP: IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen. Vaccine. 18:2002–2008. 2000.PubMed/NCBI View Article : Google Scholar
12	Chang CY, Lee J, Kim EY, Park HJ, Kwon CH, Joh JW and Kim SJ: Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. BMC Cancer. 7(87)2007.PubMed/NCBI View Article : Google Scholar
13	Srinivasan A, Salazar-Gonzalez RM, Jarcho M, Sandau MM, Lefrancois L and McSorley SJ: Innate immune activation of CD4 T cells in salmonella-infected mice is dependent on IL-18. J Immunol. 178:6342–6349. 2007.PubMed/NCBI View Article : Google Scholar
14	Spolski R and Leonard WJ: Interleukin-21: Basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 26:57–79. 2008.PubMed/NCBI View Article : Google Scholar
15	Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, Morse HC III, Liu C, Schwartzberg PL and Leonard WJ: A critical role for IL-21 in regulating immunoglobulin production. Science. 298:1630–1634. 2002.PubMed/NCBI View Article : Google Scholar
16	Pot C, Jin H, Awasthi A, Liu SM, Lai CY, Madan R, Sharpe AH, Karp CL, Miaw SC, Ho IC and Kuchroo VK: Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol. 183:797–801. 2009.PubMed/NCBI View Article : Google Scholar
17	Spolski R, Kim HP, Zhu W, Levy DE and Leonard WJ: IL-21 mediates suppressive effects via its induction of IL-10. J Immunol. 182:2859–2867. 2009.PubMed/NCBI View Article : Google Scholar
18	Stumhofer JS, Silver JS and Hunter CA: IL-21 is required for optimal antibody production and T cell responses during chronic Toxoplasma gondii infection. PLoS One. 8(e62889)2013.PubMed/NCBI View Article : Google Scholar
19	Strengell M, Matikainen S, Sirén J, Lehtonen A, Foster D, Julkunen I and Sareneva T: IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol. 170:5464–5469. 2003.PubMed/NCBI View Article : Google Scholar
20	Sareneva T, Matikainen S, Kurimoto M and Julkunen I: Influenza A virus-induced IFN-alpha and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol. 160:6032–6038. 1998.PubMed/NCBI
21	Nakanishi K, Yoshimoto T, Tsutsui H and Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Ann Rev Immunol. 19:423–474. 2001.PubMed/NCBI View Article : Google Scholar
22	Pirhonen J, Sareneva T, Kurimoto M, Julkunen I and Matikainen S: Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol. 162:7322–7329. 1999.PubMed/NCBI
23	Pien GC, Satoskar AR, Takeda K, Akira S and Biron CA: Cutting edge: Selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol. 165:4787–4791. 2000.PubMed/NCBI View Article : Google Scholar
24	Abdalkareem EA, Tan GC, Abdalla HS, Lim BH and Khoo BY: Identification of specific proteins in colorectal cancer patients with Schistosoma mansoni infection as a possible biomarker for the treatment of this infection. Asian Pac J Trop Dis. 4 (Suppl):S720–S724. 2014.
25	Kuppala MB, Syed SB, Bandaru S, Varre S, Akka J and Mundulru HP: Immunotherapeutic approach for better management of cancer-role of IL-18. Asian Pac J Cancer Prev. 13:5353–5361. 2012.PubMed/NCBI View Article : Google Scholar
26	Guo X, Zheng L, Jiang J, Zhao Y, Wang X, Shen M, Zhu F, Tian R, Shi C, Xu M, et al: Blocking NF-κB is essential for the immunotherapeutic effect of recombinant IL-18 in pancreatic cancer. Clin Cancer Res. 22:5939–5950. 2016.PubMed/NCBI View Article : Google Scholar
27	Wigginton JM, Lee JK, Wiltrout TA, Alvord WG, Hixon JA, Subleski J, Back TC and Wiltrout RH: Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2. J Immunol. 169:4467–4474. 2002.PubMed/NCBI View Article : Google Scholar
28	Stavropoulos NE, Ioachim E, Pappa L, Hastazeris K and Agnantis NJ: Antiproliferative activity of interferon gamma in superficial bladder cancer. Anticancer Res. 19:4529–4533. 1999.PubMed/NCBI
29	Chew LJ, King WC, Kennedy A and Gallo V: Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells. Glia. 52:127–143. 2005.PubMed/NCBI View Article : Google Scholar
30	Yasuda K, Nakanishi K and Tsutsui H: Interleukin-18 in health and disease. Int J Mol Sci. 20(649)2019.PubMed/NCBI View Article : Google Scholar
31	Gigley JP, Bhadra R and Khan IA: CD8 T cells and Toxoplasma gondii: A new paradigm. J Parasitol Res. 2011(243796)2011.PubMed/NCBI View Article : Google Scholar
32	Jensen KDC, Camejo A, Melo MB, Cordeiro C, Julien L, Grotenbreg GM, Frickel EM, Ploegh HL, Young L and Saeij JP: Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. mBio. 6(e02280)2015.PubMed/NCBI View Article : Google Scholar
33	Abdalkareem EA and Yin KB: A current perspective of schistosomiasis in association with colorectal carcinogenesis. Open Infect Dis J. 11:7–12. 2019.